1. 1) A. Beck, T. Wurch, C. Bailly, and N. Corvaia: Strategies and challenges for the next generation of therapeutic antibodies. Nat. Rev. Immunol., 10, 345–352 (2010).
2. 2) F.C. Breedveld: Therapeutic monoclonal antibodies. Lancet (London, England), 355, 735–740 (2000).
3. 3) T. Mizushima, H. Yagi, E. Takemoto, M. Shibata-Koyama, Y. Isoda, S. Iida, K. Masuda, M. Satoh, and K. Kato: Structural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycans. Genes Cells, 16, 1071–1080 (2011).
4. 4) X. Li and R.P. Kimberly: Targeting the Fc receptor in autoimmune disease. Exp. Opin. Ther. Targets, 18, 335–350 (2014).
5. 5) V.R. Gómez Román, J.C. Murray, and L.M. Weiner: Chapter 1 - Antibody-Dependent Cellular Cytotoxicity (ADCC). in Antibody Fc: Linking Adaptive and Innate Immunity, M.E. Ackerman and F. Nimmerjahn, eds., Academic Press, Boston, pp. 1–27 (2014).